Woman, 30, who went through the menopause aged 20 launches a desperate appeal to have her dream baby

Jade Burns, 30, of Essex, was devastated with a premature ovarian failure diagnosis. Her and her husband, Jon Burns, are no longer eligible for IVF in their area.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news

Related Links:

Conclusions: Bariatric surgery appears to be capable of partially reversing the obesity-related epigenome. The identification of potential epigenetic biomarkers predictive for the success of bariatric surgery may open new doors to personalized therapy for severe obesity. Introduction Obesity is currently a huge healthcare problem, worldwide, and is a risk factor for several diseases such as type 2 diabetes (T2D), cardiovascular disease and cancer (1). As the prevalence of obesity reaches pandemic proportions, this metabolic disease is estimated to become the biggest cause of mortality in the near future (2). In fact,...
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research
ConclusionThe use of lasers to treat these conditions may seem appealing; however, the lack of good-quality evidence in the form of multi-centre randomised placebo-controlled trials is concerning. The safety and effectiveness of these laser devices have not been established. Use of lasers may lead to serious adverse events such as vaginal burns, scarring, dyspareunia and chronic pain. Randomised placebo-controlled trials in addition to formal evaluation of the laser devices are required before this treatment modality can be recommended.
Source: International Urogynecology Journal - Category: OBGYN Source Type: research
 Back in February, MD+DI got the low down from an obstetrics and gynecologist specialist in Lubbock, TX on a new vaginal rejuvenation device that her patients have been raving about.  Now it seems the manufacturer of that particular device, along with other companies selling laser- or energy-based devices for vaginal rejuvenation failed to get FDA's blessing. "We've recently become aware of a growing number of manufacturers marketing 'vaginal rejuvenation' devices to women and claiming these procedures will treat conditions and symptoms related to menopause, urinary incontinence, or...
Source: MDDI - Category: Medical Devices Authors: Tags: Regulatory and Compliance Source Type: news
PMID: 30083712 [PubMed - in process]
Source: Annals of Internal Medicine - Category: Internal Medicine Authors: Tags: Ann Intern Med Source Type: research
FDA head Dr. Scott Gottlieb today released a statement warning about “vaginal rejuvenation” procedures intended to treat conditions related to menopause, urinary incontinence or sexual function, saying that the products used in the procedures “don’t have adequate evidence to support their use for this purpose.” Gottliebb said that the procedures use lasers or energy-based devices to destroy or reshape vaginal tissue, and while the FDA has approved such devices for treating serious conditions such as the destruction of abnormal or precancerous cervical or vaginal tissues, the devices and proced...
Source: Mass Device - Category: Medical Devices Authors: Tags: Food & Drug Administration (FDA) Women's Health Alma Lasers Cynosure Inc. InMode Aesthetic Solutions sciton Source Type: news
The agency told seven companies that sell lasers for cosmetic gynecology and related procedures to stop marketing them for unapproved uses.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Laser (Light Amplification by Stimulated Emission of Radiation) Advertising and Marketing Menopause Medical Devices Food and Drug Administration Sciton Alma Lasers Thermigen Cynosure Vagina BTL Industries Inmode Source Type: news
Muffin top. Spare tire. Beer belly. Whatever you call it, research shows that extra fat around your belly poses a unique health threat. The study in the March 6, 2018 issue of the Journal of the American Heart Association involved about 500,000 people, ages 40 to 69, in the United Kingdom. The researchers took body measurements of the participants and then kept track of who had heart attacks over the next seven years. During that period, the women who carried more weight around their middles (measured by waist circumference, waist-to-hip ratio, or waist-to-height ratio) had a 10% to 20% greater risk of heart attack than wo...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Diet and Weight Loss Health Heart Health Source Type: blogs
Conclusions: A larger proportion of women whose MBS improved had a Lactobacillus dominant microbiota at enrollment than those who had no improvement during the trial, though this difference was not statistically significant. Larger trials are needed to determine whether vaginal microbiota modify or mediate treatment responses in women with GSM.
Source: Menopause - Category: OBGYN Tags: Original Articles Source Type: research
Women who take hormone replacement therapies to ease the symptoms of menopause weigh slightly less and have significantly less belly fat - so long as they keep up the drugs, a new Swiss study reveals.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Discussion From Beth Israel Deaconess Medical Center. Ann Intern Med. 2018 Feb 06;168(3):203-209 Authors: Reynolds EE, Bates C, Richardson M, Burns RB Abstract Hormone therapy (HT) was widely prescribed in the 1980s and 1990s and has been controversial since the initial results of the Women's Health Initiative (WHI) trial in the early 2000s suggested that it increased risk for breast cancer and coronary heart disease and did not prolong life. However, more recent data and reexamination of the WHI results suggest that HT is safe and effective for many women when used around the time of menopause. Two e...
Source: Annals of Internal Medicine - Category: Internal Medicine Authors: Tags: Ann Intern Med Source Type: research
More News: Babies | Burns | Health | Men | Menopause | Ovaries | Perinatology & Neonatology